The National Science Foundation has awarded a $250,000 grant to BioAesthetics Corp. to develop a new advanced wound-care product for treating bed sores or pressure ulcers. The product will be tested at Tulane University.

Two professors in Tulane University’s School of Professional Advancement’s Emergency & Security Studies Program have recently partnered with the Naval Postgraduate School (NPS) Center for Homeland Defense and Security (CHDS) to establish Pracademic Affairs, a journal featuring the work and experiences of practitioners in the fields of emergency management and homeland security/defense, for use in higher education.

For the first time, Tulane University researchers have identified and replicated a little understood, hyperimmune response in nonhuman primates that could one day lead to treatments to rescue patients with severe cases of the disease. Their findings were published in The American Journal of Pathology.

Tulane University has been designated as a COVID-19 vaccine provider site by the Louisiana Department of Health and will become one of the first universities in the state to begin administering doses of COVID-19 vaccine. The designation allows Tulane to receive vaccines directly from manufacturers and rapidly mobilize staff to provide immunizations for those in the university community who are eligible under state guidelines. 

Reopening K-12 schools in the United States did not result in an increase in hospitalizations  — in most cases —  due to COVID-19, according to a new study by the National Center for Research on Education Access and Choice (REACH) at Tulane University. 

Five new members have joined the Board of Tulane, the university’s main governing body.

“These individuals have an incredible legacy of commitment to and support of Tulane and numerous other institutions across the country,” Tulane President Michael Fitts said. “Through their love and commitment to Tulane, I know that they will provide the best counsel and leadership for our university.”